NewAmsterdam Pharma (NAMS) Exchange Rate Effect (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported Exchange Rate Effect of -$1.3 million for Q1 2026, down 135.32% on a YoY basis from $3.8 million in Q1 2025, and down 2120.0% sequentially from -$60000.0 in Q4 2025.
NewAmsterdam Pharma (NAMS) Exchange Rate Effect (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 4 years of Exchange Rate Effect data on file, last reported at -$1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 135.32% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (up 1531.03% YoY), and the FY2025 full-year result was $12.8 million, up 287.58% from the prior year.
- Exchange Rate Effect slipped to -$1.3 million in Q1 2026, from -$60000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $8.8 million in Q2 2025 to a low of -$9.7 million in Q2 2023.
- A 4-year average of $126033.9 and a median of -$60000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect sank 252.05% in 2024 and soared 1070.96% in 2025, its largest moves.
- Tracing NAMS's Exchange Rate Effect over 4 years: stood at $5.2 million in 2023, then slumped by 252.05% to -$7.9 million in 2024, then soared by 99.24% to -$60000.0 in 2025, then slumped by 2120.0% to -$1.3 million in 2026.
- Business Quant data shows NAMS's Exchange Rate Effect at -$1.3 million in Q1 2026, -$60000.0 in Q4 2025, and $222000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NewAmsterdam Pharma | 3.72 Bn | 3.72 Bn | - | -1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Dec 31, 2025 | -60,000.00 |
| Dec 31, 2025 | -60,000.00 |
| Sep 30, 2025 | 222,000.00 |
| Sep 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 8.83 Mn |
| Jun 30, 2025 | 8.83 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | -7.94 Mn |
| Dec 31, 2024 | -7.94 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | -909,000.00 |
| Jun 30, 2024 | -909,000.00 |
| Mar 31, 2024 | -2.50 Mn |
| Mar 31, 2024 | -2.50 Mn |
| Dec 31, 2023 | 5.22 Mn |
| Dec 31, 2023 | 5.22 Mn |